Advanced Oncology & Metabolic Restoration
Multi-system metabolic reset, immune restoration, and cellular repair for individuals navigating aggressive oncological challenges
An advanced, multi-phase protocol designed to fundamentally reprogram cellular energy production, dismantle the metabolic conditions that favor malignant proliferation, restore exhausted immune pathways, and repair collateral tissue damage. This protocol leverages mitochondrial-targeted peptides alongside metabolic correctors, immunomodulators, and antiparasitic compounds with emerging cytotoxic properties. It is structured in three distinct phases — metabolic priming, intensive intervention, and long-term maintenance — and must be conducted under direct medical supervision.
Peptides Involved
💉 Dosing Schedule
Dose
5 mg every other day
Frequency
Every 48 hours
Timing
Morning subcutaneous injection, rotate abdomen/thigh/deltoid
Dose
2 mg/day
Frequency
Daily
Timing
Morning subcutaneous injection
Dose
0.5 mg/week
Frequency
Once weekly
Timing
Monday morning subcutaneous injection
Dose
1 mg/day
Frequency
Daily
Timing
Morning subcutaneous injection
Dose
5 mg every 5 days
Frequency
Every 5 days
Timing
Morning subcutaneous injection
Dose
500 mcg/week
Frequency
Once weekly
Timing
Monday subcutaneous injection
Dose
7 mg/day → 3.5 mg/day
Frequency
Daily patch application
Timing
Apply to clean dry skin each morning, rotate placement sites
Dose
0.2 mg/kg/day orally
Frequency
Daily for 30 days
Timing
Oral with food, Phase 2 only
Dose
222 mg orally
Frequency
3 days on / 4 days off for 30 days
Timing
Oral with food, Phase 2 only
📅 Cycle Structure
12+ weeks initial course, then indefinite maintenance
📊 Phase Breakdown
Phase 1: Mitochondrial Priming & Metabolic Reset
Weeks 1–3Begin with MOTS-c alone (5 mg subcutaneous every 48 hours, mornings). The objective is to activate AMPK-driven oxidative phosphorylation pathways, forcing a shift away from glycolytic dependence. This metabolic reset phase starves aberrant cells of their preferred fuel while restoring efficient ATP generation in healthy tissue. Simultaneously introduce all lifestyle interventions: 18:6 intermittent fasting, Mediterranean-carnivore hybrid diet (zero processed sugar), daily walking, and environmental toxin reduction.
Phase 2: Full-Spectrum Intervention
Weeks 4–12Layer the complete therapeutic stack on top of MOTS-c. SS-31 stabilizes mitochondrial cardiolipin and clears reactive oxygen species at the electron transport chain. Retatrutide corrects systemic insulin resistance and enhances immune cell tumor infiltration via triple-receptor agonism. BPC-157 drives tissue regeneration and gut barrier repair while modulating angiogenesis. TB-500 promotes healthy tissue remodeling and disrupts pathological microenvironments. Thymosin Alpha-1 rescues T-cell and NK-cell function from exhaustion. Nicotine patches engage cholinergic anti-inflammatory signaling to suppress systemic TNF-alpha. Ivermectin (daily x 30 days) and Fenbendazole (3 on/4 off x 30 days) exploit microtubule disruption and glucose uptake blockade in malignant cells.
Phase 3: Long-Term Maintenance
Post-Week 12, ongoingContinue all peptides at established doses indefinitely. Discontinue Ivermectin and Fenbendazole after their initial 30-day courses, cycling them for 30 days every 3–6 months as needed. Reduce Nicotine to 3.5 mg/day maintenance dose. Continue all dietary and lifestyle interventions. Quarterly imaging and monthly bloodwork guide adjustments.
💡 Notes & Tips
- EXPERIMENTAL PROTOCOL — requires direct medical supervision at all times
- Injection technique: alcohol swab site, pinch skin, 45–90° angle with insulin syringe, slow injection, rotate sites systematically
- Strict 18:6 intermittent fasting (e.g. noon–6 PM eating window) to drive autophagy and suppress glycolytic fuel availability
- Diet: high-quality animal proteins, fatty fish, healthy fats, minimal low-toxicity vegetables — zero sugar, zero processed food
- Daily movement: minimum 1-mile walk at a moderate 16-minute-mile pace for circulation and lymphatic drainage
- Herbal adjuncts: black walnut hull, wormwood, and clove complex (50 mg each daily) for antiparasitic synergy
- Minimize environmental oxidative stressors — consider EMF-reducing measures in sleeping areas
- Monitoring: weekly symptom journal (pain/fatigue/weight on 0–10 scales), monthly comprehensive bloodwork (tumor markers, CRP, metabolic panel, CBC), quarterly imaging (CT/MRI/PET)
- Target outcomes: undetectable tumor markers, normalized inflammatory markers, and confirmed sustained remission within the initial 12-week intensive course
- Common side effects: mild nausea from Retatrutide (usually transient), injection site reactions, nicotine patch skin irritation — start at lower dose if sensitive
- Contraindicated in pregnancy — monitor cardiovascular parameters closely with nicotine and Retatrutide
Medical Disclaimer
This protocol is for informational purposes only. Dosing guidelines are based on community reports and limited research — not clinical trials. Always consult a qualified healthcare provider before starting any peptide protocol.